Follow-up study after "A Single-Center, Single-Arm Study to Evaluate the Efficacy of Antibiotics-combined Fecal Microbiota Transplantation in Active Crohn's Disease"

Follow-up study after "A Single-Center, Single-Arm Study to Evaluate the Efficacy of Antibiotics-combined Fecal Microbiota Transplantation in Active Crohn's Disease" - Follow-up study after A-FMT for active crohn's disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061011

Enrollment

Registered

2026-03-23

Start date

2026-03-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who participated in the ongoing clinical study titled "A Single-Center, Single-Arm Study to Evaluate the Efficacy of Antibiotics-combined Fecal Microbiota Transplantation in Active Crohn's Disease".

Exclusion criteria

Exclusion criteria: Patients deemed unsuitable as subjects by the principal investigator

Design outcomes

Primary

Measure	Time frame
At baseline, 3 months, 6 months, 9 months, and 12 months, medical evaluation will be performed using the Harvey-Bradshaw Index (HBI) symptom score. General physical condition, presence of abdominal pain, number of watery stools per day, presence of abdominal mass, presence of complications (arthralgia, uveitis, erythema nodosum, aphthous ulcers, pyoderma gangrenosum, anal fissure, new fistula, abscess)	—

Measure

Time frame

At baseline, 3 months, 6 months, 9 months, and 12 months, medical evaluation will be performed using the Harvey-Bradshaw Index (HBI) symptom score. General physical condition, presence of abdominal pain, number of watery stools per day, presence of abdominal mass, presence of complications (arthralgia, uveitis, erythema nodosum, aphthous ulcers, pyoderma gangrenosum, anal fissure, new fistula, abscess)

—

Countries

Japan

Contacts

Public ContactDai Ishikawa

Juntendo University Hospital Department of Gastroenterology

dai@juntendo.ac.jp03-3813-3111

Outcome results